OGT Method for Gastric Cancer Surgery
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
Recruiting
N/A
Interventional Study
Gastric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 344 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Other
Who this trial is looking for
This trial is looking for adults with gastric cancer to compare a new surgical method with a traditional one. Participants will undergo a specific type of surgery for their condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 75 years old
- I have been diagnosed with gastric adenocarcinoma
- I am expected to live more than 1 year
- My tumor is located in the gastroesophageal junction or stomach
- I have not had upper abdominal surgery before
- My performance status is 0 or 1
- I have not had any preoperative radiotherapy
- I have sufficient organ functions
You may not be able to join if
- I am pregnant or breastfeeding
- I have a body temperature of 38 °C or higher before surgery
- I have severe mental disease
- I have confirmed stage IV cancer during surgery
- I have severe respiratory disease
- I have severe liver or kidney dysfunction
- I have unstable angina or a heart attack history in the last 6 months
- I have had a stroke or brain bleeding in the last 6 months
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Abstract Background Our previous studies have shown OGT method significantly simplified overlap esophagojejunostomy with good short-term outcomes, and provided new perspectives for optimizing esophagojejunostomy. However, the safety and efficiency of OGT method still need evidence of randomized controlled trial.
Methods: This trial is a prospective, multicenter, randomized, controlled, open, and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged 18-75 years;
* Primary lesion is pathologically diagnosed as gastric adenocarcinoma;
* Expected to live more than 1 year;
* Tumor located located in gastroesophageal junction (GEJ) involve esophagus no more than 2cm, or in the upper, upper to middle, or entire stomach, an…
Contacts